BRIJ Medical’s BRIJ-SEAL™ Advanced Wound Sealant Earns Breakthrough Technology Designation from Premier, Inc. for Enhanced Post-Operative Care

Morningstar / PR Newswire USA

Overview

BRIJ Medical’s BRIJ-SEAL™ advanced wound sealant has received a Breakthrough Technology designation from Premier, Inc., a leading U.S. healthcare company. This innovative, single-use, sterile, and hypoallergenic adhesive is designed to seal, protect, and reinforce post-operative incisions, providing a 14-day bacterial barrier while remaining breathable and flexible. Unlike traditional cyanoacrylate adhesives, BRIJ-SEAL™ utilizes a proprietary hypoallergenic technology, aiming to significantly improve healing outcomes and patient satisfaction, marking a crucial advancement in medical adhesives.

In Depth

Key Findings

BRIJ Medical’s innovative advanced wound sealant, BRIJ-SEAL™, has been awarded a Breakthrough Technology designation by Premier, Inc., a prominent U.S. healthcare improvement company. This designation signifies that BRIJ-SEAL™ possesses the potential to substantially enhance patient care and clinical outcomes through its groundbreaking technology.

Technical Details

BRIJ-SEAL™ is a single-use, sterile, and hypoallergenic adhesive specifically engineered to effectively seal, protect, and reinforce post-operative incisions. A key differentiator is its proprietary hypoallergenic adhesive technology, which significantly mitigates the risks of skin irritation and allergic reactions often associated with conventional cyanoacrylate-based adhesives. The sealant provides a robust bacterial barrier for up to 14 days post-application, thereby reducing infection risks. Concurrently, it maintains breathability and flexibility, enhancing patient comfort and allowing for natural skin respiration. This optimized healing environment contributes to faster patient recovery and a reduction in post-operative complications.

Background & Context

Managing post-surgical incisions remains a critical challenge in healthcare, encompassing infection prevention, pain management, and cosmetic outcomes. Traditional wound closure methods, including sutures, staples, and general adhesives, each have inherent limitations. For instance, some adhesives can induce skin irritation, and their bacterial barrier capabilities may be insufficient. Advanced wound sealants like BRIJ-SEAL™ are designed to overcome these challenges, offering a safer and more effective solution for post-operative care, thus improving overall medical outcomes. The designation by Premier, Inc. is a pivotal step towards accelerating broader adoption in the healthcare sector and improving access to innovative treatment options.

Strategic Significance & Outlook

The Breakthrough Technology designation for BRIJ-SEAL™ signals its potential to transform the standard of post-operative care in hospitals and clinics. Patients can anticipate reduced infection risks, accelerated recovery, and a more comfortable experience. For healthcare providers, it introduces a new tool that is easy to use, highly safe, and clinically effective. Moving forward, BRIJ Medical is expected to leverage this designation to expand its application across a wider range of clinical procedures and pursue international market penetration. In the surgical adhesives and sealants market, this hypoallergenic, high-performance solution is poised to gain a significant competitive advantage and accelerate the advancement of medical technology.

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

• Your email and selected fields are used only to deliver the newsletter.
• We never share your information with third parties.
• You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Agree & Continue ▶

Takes about a minute · Unsubscribe anytime